期刊文献+

Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 被引量:3

Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up
下载PDF
导出
摘要 AIM: To assess the evolution of duodenal lymphocytosis(DL), a condition characterized by increased intraepithelial lymphocytes(IELs), over 2 years of follow-up.METHODS: Consecutive patients undergoing upper endoscopy/histology for abdominal pain, diarrhea, weight loss, weakness or other extraintestinal features compatible with celiac disease(CD) were included. Evaluation of IELs infiltrate in duodenal biopsy sampleswas carried out by CD3-immunohistochemistry and expressed as number of positive cells/100 enterocytes. Diagnostic agreement on the IELs count was tested by calculating the weighted k coefficient. All patients underwent serological detection of autoantibodies associated with CD: Ig G and Ig A anti-tissue transglutaminase and endomysium. Each patient underwent further investigations to clarify the origin of DL at baseline and/or in the course of 2 years of follow-up every six months. Autoimmune thyroiditis, intestinal infections, parasitic diseases, bacterial intestinal overgrowth, hypolactasia and wheat allergy were detected. Colonoscopy and enteric magnetic resonance i m a g i n g w e r e p e r f o r m e d w h e n n e c e s s a r y. R i s k factors affecting the final diagnosis were detected by multinomial logistic regression and expressed as OR.RESULTS: Eighty-five patients(16 males, 69 females, aged 34.1 ± 12.5 years) were followed up for a mean period of 21.7 ± 11.7 mo. At baseline, endoscopy/duodenal biopsy, CD3 immunohistochemistry revealed: > 25 IELs/100 enterocytes in 22 subjects, 15-25 IELs in 37 and < 15 IELs in 26. They all had negative serum anti-transglutaminase and anti-endomysium, whilst 5 showed Ig G anti-gliadin positivity. In the course of follow-up, 23 developed CD seropositivity and gluten sensitivity(GS) was identified in 19. Other diagnoses were: 5 Helicobacter pylori infections, 4 jejunal Crohn's disease, 1 lymphocytic colitis and 1 systemic sclerosis. The disease in the remaining 32 patients was classified as irritable bowel syndrome because of the lack of diagnostic evidence. AIM: To assess the evolution of duodenal lymphocytosis(DL), a condition characterized by increased intraepithelial lymphocytes(IELs), over 2 years of follow-up.METHODS: Consecutive patients undergoing upper endoscopy/histology for abdominal pain, diarrhea, weight loss, weakness or other extraintestinal features compatible with celiac disease(CD) were included. Evaluation of IELs infiltrate in duodenal biopsy sampleswas carried out by CD3-immunohistochemistry and expressed as number of positive cells/100 enterocytes. Diagnostic agreement on the IELs count was tested by calculating the weighted k coefficient. All patients underwent serological detection of autoantibodies associated with CD: Ig G and Ig A anti-tissue transglutaminase and endomysium. Each patient underwent further investigations to clarify the origin of DL at baseline and/or in the course of 2 years of follow-up every six months. Autoimmune thyroiditis, intestinal infections, parasitic diseases, bacterial intestinal overgrowth, hypolactasia and wheat allergy were detected. Colonoscopy and enteric magnetic resonance i m a g i n g w e r e p e r f o r m e d w h e n n e c e s s a r y. R i s k factors affecting the final diagnosis were detected by multinomial logistic regression and expressed as OR.RESULTS: Eighty-five patients(16 males, 69 females, aged 34.1 ± 12.5 years) were followed up for a mean period of 21.7 ± 11.7 mo. At baseline, endoscopy/duodenal biopsy, CD3 immunohistochemistry revealed: > 25 IELs/100 enterocytes in 22 subjects, 15-25 IELs in 37 and < 15 IELs in 26. They all had negative serum anti-transglutaminase and anti-endomysium, whilst 5 showed Ig G anti-gliadin positivity. In the course of follow-up, 23 developed CD seropositivity and gluten sensitivity(GS) was identified in 19. Other diagnoses were: 5 Helicobacter pylori infections, 4 jejunal Crohn's disease, 1 lymphocytic colitis and 1 systemic sclerosis. The disease in the remaining 32 patients was classified as irritable bowel syndrome because of the lack of diagnostic evidence.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第24期7545-7552,共8页 世界胃肠病学杂志(英文版)
关键词 DUODENAL LYMPHOCYTOSIS CELIAC DISEASE Gluten sensitivity SERONEGATIVE CELIAC DISEASE Intraepitheliallymphocytes Immunohistochemistry Duodenal lymphocytosis Celiac disease Gluten sensitivity Seronegative celiac disease Intraepithelial lymphocytes Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献31

  • 1Hugh James Freeman.Risk factors in familial forms of celiac disease[J].World Journal of Gastroenterology,2010,16(15):1828-1831. 被引量:4
  • 2Francesco Cataldo,Giuseppe Montalto.Celiac disease in the developing countries: A new and challenging public health problem[J].World Journal of Gastroenterology,2007,13(15):2153-2159. 被引量:16
  • 3Drossman DA,Corazziari E,Talley NJ,Thompson WG,Whitehead WE,editors.Rome II.The functional gastrointesti-nal disorders:Diagnosis,pathophysiology and treatment:A Multinational consensus.2nd ed.McLean,Va:Degnon and Associates,2000. 被引量:1
  • 4Olden KW.Diagnosis of irritable bowel syndrome.Gastroenterology 2002; 122:1701-1714. 被引量:1
  • 5Frissora CL,Koch KL.Symptom overlap and comorbidity www.wjgnet.comof irritable bowel syndrome with other conditions.Curr Gastroenterol Rep 2005; 7:264-271. 被引量:1
  • 6Sanders DS,Carter MJ,Hurlstone DP,Pearce A,Ward AM,McAlindon ME,Lobo AJ.Association of adult coeliac disease with irritable bowel syndrome:a case-control study in patients fulfilling ROME II criteria referred to secondary care.Lancet 2001; 358:1504-1508. 被引量:1
  • 7Zipser RD,Patel S,Yahya KZ,Baisch DW,Monarch E.Presentations of adult celiac disease in a nationwide patient support group.Dig Dis Sci 2003; 48:761-764. 被引量:1
  • 8Wahnschaffe U,Ullrich R,Riecken EO,Schulzke JD.Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome.Gastroenterology 2001; 121:1329-1338. 被引量:1
  • 9Bottaro G,Cataldo F,Rotolo N,Spina M,Corazza GR.The clinical pattern of subclinical/silent celiac disease:an analysis on 1026 consecutive cases.Am J Gastroenterol 1999;94:691-696. 被引量:1
  • 10Green PHR,Stavropoulos SN,Panagi SG,Goldstein SL,Mcmahon DJ,Absan H,Neugut AI.Characteristics of adult celiac disease in the USA:results of a national survey.Am J Gastroenterol 2001; 96:126-131. 被引量:1

共引文献20

同被引文献46

  • 1Mariabeatrice Principi,Alfredo Di Leo,Maria Pricci,Maria Principia Scavo,Raffaella Guido,Sabina Tanzi,Domenico Piscitelli,Antonio Pisani,Enzo Ierardi,Maria Cristina Comelli,Michele Barone.phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study[J].World Journal of Gastroenterology,2013,19(27):4325-4333. 被引量:3
  • 2Carlo Calabrese,Chiara Praticò,Andrea Calafiore,Maurizio Coscia,Lorenzo Gentilini,Gilberto Poggioli,Paolo Gionchetti,Massimo Campieri,Fernando Rizzello.Eviendep~ reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouchanal anastomosis[J].World Journal of Gastroenterology,2013,19(34):5671-5677. 被引量:3
  • 3Roberto Bringiotti,Enzo Ierardi,Rosa Lovero,Giuseppe Losurdo,Alfredo Di Leo,Mariabeatrice Principi.Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?[J].World Journal of Gastrointestinal Pathophysiology,2014,5(4):550-559. 被引量:20
  • 4Gilles Gargala,Stéphane Lecleire,Arnaud Franois,Serge Jacquot,Pierre Déchelotte,Jean Jacques Ballet,Loic Favennec,Philippe Ducrotté.Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia[J].World Journal of Gastroenterology,2007,13(16):2333-2338. 被引量:3
  • 5Mariabeatrice Principi,Nicola De Tullio,Maria Principia Scavo,Domenico Piscitelli,Andrea Marzullo,Silvana Russo,Francesca Albano,Katia Lofano,Samanta Papagni,Michele Barone,Enzo Ierardi,Alfredo Di Leo.Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: A preliminary report[J].Scandinavian Journal of Gastroenterology.2012(10) 被引量:2
  • 6Brian Kim,Francis M. Giardiello.Chemoprevention in familial adenomatous polyposis[J]. Best Practice & Research Clinical Gastroenterology . 2011 (4) 被引量:2
  • 7Half Elizabeth,Bercovich Dani,Rozen Paul.Familial adenomatous polyposis. Orphanet journal of rare diseases . 2009 被引量:2
  • 8Vasen HF,M?slein G,Alonso A,Aretz S,Bernstein I,Bertario L,Blanco I,Bülow S,Burn J,Capella G,Colas C,Engel C,Frayling I,Friedl W,Hes FJ,Hodgson S,J?rvinen H,Mecklin JP,M?ller P,Myrh?i T,Nagengast FM,Parc Y,Phillips R,Clark SK,de Leon MP,Renkonen-Sinisalo.Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut . 2008 被引量:3
  • 9Afsaneh Barzi,Annika Medea Lenz,Melissa J. Labonte,Heinz-Josef Lenz.??Molecular Pathways: Estrogen Pathway in Colorectal Cancer(J)Clinical Cancer Research . 2013 (21) 被引量:3
  • 10Martineti Valentina,Picariello Lucia,Tognarini Isabella,Carbonell Sala Silvia,Gozzini Alessia,Azzari Chiara,Mavilia Carmelo,Tanini Annalisa,Falchetti Alberto,Fiorelli Gianna,Tonelli Francesco,Brandi Maria Luisa.ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocrine Related Cancer . 2005 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部